Pacira | PCRX - Stock


Pacira reported $134.57M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Astellas Pharma JPY 331.01B 33.75B Mar/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Cara Therapeutics USD 900K 0 Mar/2025
Coherus Biosciences USD 5.67M 842K Jun/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
J&J USD 15.14B 561M Jun/2026
Ligand Pharmaceuticals USD 10.26M 3M Jun/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novo Nordisk DKK 45.65B 21.26B Jun/2025
Omeros USD 712K 266K Sep/2021
Pacira USD 134.57M 15.8M Jun/2026
Perrigo USD 1.06B 56.9M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
Supernus Pharmaceuticals USD 107.03M 3.74M Jun/2026
Teva Pharmaceutical Industries USD 3.18B 3M Mar/2026
Xeris Pharmaceuticals USD 80.93M 6.7M Jun/2026
Zoetis USD 2.57B 24M Jun/2026